Prognostic risk classification for biochemical relapse-free survival in patients with oligorecurrent prostate cancer after [Ga-68]PSMA-PET-guided metastasis-directed therapy

Vogel, Marco M. E.; Kroeze, Stephanie G. C.; Henkenberens, Christoph; Schmidt-Hegemann, Nina-Sophie; Kirste, Simon; Becker, Jessica; Burger, Irene A.; Derlin, Thorsten; Bartenstein, Peter; Mix, Michael; la Fougere, Christian; Eiber, Matthias; Christiansen, Hans; Belka, Claus; Grosu, Anca L.; Mueller, Arndt-Christian; Guckenberger, Matthias; Combs, Stephanie E.

Prognostic risk classification for biochemical relapse-free survival in patients with oligorecurrent prostate cancer after [Ga-68]PSMA-PET-guided metastasis-directed therapy

Autor(en):

Vogel, Marco M. E.; Kroeze, Stephanie G. C.; Henkenberens, Christoph; Schmidt-Hegemann, Nina-Sophie; Kirste, Simon; Becker, Jessica; Burger, Irene A.; Derlin, Thorsten; Bartenstein, Peter; Mix, Michael; la Fougere, Christian; Eiber, Matthias; Christiansen, Hans; Belka, Claus; Grosu, Anca L.; Mueller, Arndt-Christian; Guckenberger, Matthias; Combs, Stephanie E.

Tübinger Autor(en):

Becker, Jessica
La Fougère, Christian Jean
Müller, Arndt-Christian

Erschienen in:

European Journal of Nuclear Medicine and Molecular Imaging (2020), Bd. 47, S. 2328-2338

Verlagsangabe:

Springer

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1007/s00259-020-04760-8

ISSN:

1619-7089